After finishing at $35.50 in the prior trading day, Staar Surgical Co. (NASDAQ: STAA) closed at $35.11, down -1.10%. In other words, the price has decreased by -$0.39 from its previous closing price. On the day, 769277 shares were traded.
Ratios:
Our goal is to gain a better understanding of STAA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.08 and its Current Ratio is at 5.62. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.08.
On December 04, 2023, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $35.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 08 ’24 when BROADWOOD PARTNERS, L.P. bought 4,042 shares for $27.11 per share. The transaction valued at 109,570 led to the insider holds 10,768,430 shares of the business.
BROADWOOD PARTNERS, L.P. bought 156,734 shares of STAA for $4,463,231 on Jan 05 ’24. The 10% Owner now owns 10,764,388 shares after completing the transaction at $28.48 per share. On Jan 04 ’24, another insider, BROADWOOD PARTNERS, L.P., who serves as the 10% Owner of the company, bought 63,246 shares for $28.91 each. As a result, the insider paid 1,828,183 and bolstered with 10,607,654 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STAA now has a Market Capitalization of 1.74B and an Enterprise Value of 1.55B. As of this moment, Staar’s Price-to-Earnings (P/E) ratio for their current fiscal year is 81.22, and their Forward P/E ratio for the next fiscal year is 39.59. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.71. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.32 while its Price-to-Book (P/B) ratio in mrq is 4.44. Its current Enterprise Value per Revenue stands at 4.81 whereas that against EBITDA is 46.70.
Stock Price History:
Over the past 52 weeks, STAA has reached a high of $73.13, while it has fallen to a 52-week low of $26.66. The 50-Day Moving Average of the stock is 30.77, while the 200-Day Moving Average is calculated to be 40.90.
Shares Statistics:
The stock has traded on average 748.60K shares per day over the past 3-months and 688.86k shares per day over the last 10 days, according to various share statistics. A total of 48.84M shares are outstanding, with a floating share count of 48.35M. Insiders hold about 1.06% of the company’s shares, while institutions hold 105.57% stake in the company. Shares short for STAA as of Feb 15, 2024 were 6.45M with a Short Ratio of 8.61, compared to 6.48M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 13.20% and a Short% of Float of 27.34%.
Earnings Estimates
Its stock is currently analyzed by 9 different market analysts. On average, analysts expect EPS of $0.03 for the current quarter, with a high estimate of $0.11 and a low estimate of -$0.05, while EPS last year was $0.18. The consensus estimate for the next quarter is $0.24, with high estimates of $0.34 and low estimates of $0.17.
Analysts are recommending an EPS of between $0.74 and $0.3 for the fiscal current year, implying an average EPS of $0.57. EPS for the following year is $0.95, with 9 analysts recommending between $1.18 and $0.66.
Revenue Estimates
11 analysts predict $72.13M in revenue for the current quarter. It ranges from a high estimate of $72.6M to a low estimate of $72M. As of the current estimate, Staar Surgical Co.’s year-ago sales were $66.96M, an estimated increase of 7.70% from the year-ago figure. For the next quarter, 11 analysts are estimating revenue of $94.86M, an increase of 2.80% less than the figure of $7.70% in the same quarter last year. There is a high estimate of $97.8M for the next quarter, whereas the lowest estimate is $93M.
A total of 12 analysts have provided revenue estimates for STAA’s current fiscal year. The highest revenue estimate was $338.9M, while the lowest revenue estimate was $335.71M, resulting in an average revenue estimate of $337.06M. In the same quarter a year ago, actual revenue was $322.42M, up 4.50% from the average estimate. Based on 12 analysts’ estimates, the company’s revenue will be $391.68M in the next fiscal year. The high estimate is $403.3M and the low estimate is $382M. The average revenue growth estimate for next year is up 16.20% from the average revenue estimate for this year.
